Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 3/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.35 |
| ▸ | RPLP1 | P05386 | 2/20 | 0.35 |
| ▸ | RPLP0 | P05388 | 2/20 | 0.35 |
| ▸ | RPS17 | P08708 | 2/20 | 0.35 |
| ▸ | RPSA | P08865 | 2/20 | 0.35 |
| ▸ | RPS2 | P15880 | 2/20 | 0.35 |
| ▸ | RPL35A | P18077 | 2/20 | 0.35 |
| ▸ | RPL7 | P18124 | 2/20 | 0.35 |
| ▸ | RPL17 | P18621 | 2/20 | 0.35 |
| ▸ | RPS4Y1 | P22090 | 2/20 | 0.35 |
| ▸ | RPS3 | P23396 | 2/20 | 0.35 |
| ▸ | RPS12 | P25398 | 2/20 | 0.35 |
| ▸ | RPL13 | P26373 | 2/20 | 0.35 |
| ▸ | RPL10 | P27635 | 2/20 | 0.35 |
| ▸ | RPL12 | P30050 | 2/20 | 0.35 |
| ▸ | RPL9; RPL9P7; RPL9P8; RPL9P9 | P32969 | 2/20 | 0.35 |
| ▸ | RPL22 | P35268 | 2/20 | 0.35 |
| ▸ | RPL4 | P36578 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2080657 | 0.84 | SLC6A4 (0.40) | SSTR4SLC6A2SLC6A4SLC6A3CHRM2 | |
| SCHEMBL2086006 | 0.70 | CXCR4 (0.42) | SSTR4RPLP1RPLP0RPS17RPSA | |
| SCHEMBL7140521 | 0.70 | NOS3 (0.47) | SSTR4CXCR4 | |
| SCHEMBL19214826 | 0.68 | NOS3 (0.45) | SSTR4CHRNA4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2083712 | 0.66 | NOS3 (0.40) | SSTR4CHRM2CHRM1CHRM3CXCR4 | |
| SCHEMBL10153575 | 0.66 | CHRNB2 (0.56) | CHRNB2CHRNA4 | |
| SCHEMBL20031862 | 0.66 | NOS3 (0.42) | SSTR4CXCR4 | |
| SCHEMBL17849499 | 0.66 | SSTR4 (0.47) | SSTR4CXCR4 | |
| SCHEMBL23889117 | 0.65 | OPRL1 (0.45) | SSTR4CXCR4 | |
| SCHEMBL19214821 | 0.65 | NOS3 (0.41) | SSTR4CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7863293-B2 | CXCR4 chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2011-01-04 | — | — | US | claimed |
| US-20080255197-A1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED CORPORATION (CA) | 2008-10-16 | — | — | US | claimed |
| US-7291631-B2 | CXCR4 chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2007-11-06 | — | — | US | claimed |
| EP-1613613-B1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | GENZYME CORP (US) | 2021-06-02 | — | — | EP | disclosed |
| US-7863293-B2 | CXCR4 chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2011-01-04 | — | — | US | disclosed |
| EP-1613613-A4 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC (CA) | 2009-03-25 | — | — | EP | disclosed |
| US-20080255197-A1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED CORPORATION (CA) | 2008-10-16 | — | — | US | disclosed |
| US-7291631-B2 | CXCR4 chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2007-11-06 | — | — | US | disclosed |
| EP-1613613-A2 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC. (CA) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004091518-A2 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC. (CA) | 2004-10-28 | — | — | WO | disclosed |
| US-20040209921-A1 | CXCR4 chemokine receptor binding comounds | ANORMED CORPORATION (CA) | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209921-A1 | CXCR4 chemokine receptor binding comounds | CXCR4, CXCR1, CXCR3 | SSTR4 4293/4885CHRNB2 1753/4885CHRNA4 1557/4885 |
| US-20080255197-A1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | CXCR4, CXCR1, CXCR3 | SSTR4 3287/4885CHRNB2 1799/4885CHRNA4 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.